1. Catalog
  2. WCLC 2025 - Posters & ePosters
  3. PT1.07.03 Adjuvant Osimertinib in IB-IIIB NSCLC wi ...
PT1.07.03 Adjuvant Osimertinib in IB-IIIB NSCLC with Uncommon EGFR Mutations (Admin): Mutation Profile and ctDNA Dynamics
Back to course
Asset Subtitle
Chengwu Liu
Meta Tag
Speaker Chengwu Liu
Topic Early-Stage Non-small Cell Lung Cancer
Powered By